Nausea and vomiting. Nausea and vomiting
Conditions
Interventions
Intervention 1: Intervention group: The study group receives 300 mg of pregabalin tablets (manufactured by Actoverco under the brand name Zoliver) one hour before entering the operating room along wit
Sponsors
Tabriz University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 55 Years
Inclusion criteria
Inclusion criteria: Healthy women in the age range of 18-55 years are candidates for outpatient laparoscopic surgery with general anesthesia
Exclusion criteria
Exclusion criteria: Dibetes Being smoker History of motion sickness Gastrointestinal disease Receiving steroids, narcotics, and antiemetics
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of nausea-vomiting. Timepoint: in recovery and 2 and 24 hours later. Method of measurement: verbal question. | — |
Secondary
| Measure | Time frame |
|---|---|
| Severity of nausea and vomiting. Timepoint: in recovery and 2 and 24 hours later. Method of measurement: by Bellville criteria.;Total dose of anti-nausea medication. Timepoint: in recovery and 2 and 24 hours later. Method of measurement: By bellville criteria.;Possible side effects. Timepoint: During the period of hospitalization in recovery until discharge. Method of measurement: observation. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFarnaz Moslemi
Tabriz University of Medical Sciences
Outcome results
None listed